2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
21
Neurofibromatosis 1
19
Neurofibroma, Plexiform
11
Melanoma
11
Lung Neoplasms
8
Neoplasms
7
Neoplasm Metastasis
7
Colorectal Neoplasms
7
Breast Neoplasms
7
Solid Tumours
5
Pancreatic Neoplasms
5
Carcinoma, Hepatocellular
4
Uveal Melanoma
3
Triple Negative Breast Neoplasms
3
Thyroid Neoplasms
3
Rectal Neoplasms
3
Neurofibrosarcoma
3
Gallbladder Neoplasms
3
Colonic Neoplasms
3
Biliary Tract Neoplasms
3
Thyroid Cancer, Papillary
2
Sarcoma
2
Bile Duct Neoplasms
2
Adult Solid Neoplasm
2
Thyroid Diseases
1
Thymoma
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Renal Insufficiency
1
Interventions
Oxaliplatin
29
Fluorouracil
25
Leucovorin
20
Capecitabine
18
Irinotecan
17
Surveys and Questionnaires
16
Bevacizumab
14
Cisplatin
12
Blood Specimen Collection
11
Drug Therapy
10
Standard of Care
9
Nivolumab
9
Gemcitabine
9
Cetuximab
7
pembrolizumab
6
Specimen Handling
6
S 1 (combination)
6
Endoscopic Mucosal Resection
6
Cyclophosphamide
6
atezolizumab
5
Sunitinib
5
Radiotherapy
5
Folfox protocol
5
Educational Status
5
Docetaxel
5
fludarabine
4
aldesleukin
4
Radiosurgery
4
Pemetrexed
4
Magnetic Resonance Spectroscopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
AZD 6244
×
Clear all
NCT02450656
2018-08-27
M14AFS
The Netherlands Cancer Institute
Phase 1/2
Unknown
320 enrolled